SCHEMBL12901767

SCHEMBL12901767

CCOC(=O)CCc1ccc(/C(Nc2ccc(CN(C)C)cc2)=C2/C(=O)N(C(C)=O)c3cc(F)ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 3/20 0.36
CETP P11597 5/20 0.36
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.35
GPBAR1 Q8TDU6 1/20 0.34
EPHX2 P34913 1/20 0.34
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
CASP3 P42574 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MITF O75030 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3666550 0.90 MCHR1 (0.39) MCHR1
SCHEMBL3666552 0.90 MCHR1 (0.39) MCHR1
SCHEMBL3529559 0.82 CYP4F2 (0.40) MAPTMEN1KMT2APOLBGPBAR1
SCHEMBL3529558 0.82 CYP4F2 (0.40) MAPTMEN1KMT2APOLBGPBAR1
SCHEMBL228101 0.82 BACE1 (0.38) MCHR1CETPMAPTMEN1KMT2A
SCHEMBL228102 0.82 BACE1 (0.38) MCHR1CETPMAPTMEN1KMT2A
SCHEMBL1943744 0.81 CYP4F2 (0.41) MAPTGPBAR1EPHX2CYP4F2CYP4A11
SCHEMBL1943746 0.81 CYP4F2 (0.41) MAPTGPBAR1EPHX2CYP4F2CYP4A11
SCHEMBL5522568 0.79 CYP4F2 (0.39) MAPTGPBAR1EPHX2CYP4F2CYP4A11
SCHEMBL3527918 0.74 GPBAR1 (0.37) MAPTMEN1KMT2APOLBGPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046395-A1 PROCESS FOR THE MANUFACTURE OF A 6-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE DERIVATIVE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-02-24 US disclosed
US-20110046395-A1 PROCESS FOR THE MANUFACTURE OF A 6-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE DERIVATIVE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-02-24 US disclosed
WO-2009092580-A1 PROCESS FOR THE MANUFACTURE OF A 6-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE DERIVATIVE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046395-A1 PROCESS FOR THE MANUFACTURE OF A 6-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE DERIVATIVE FDPS, DHPS, UGT1A6 MCHR1 2374/4885CETP 1753/4885MAPT 1811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.